Artesunate was obtained as gift sample from Ipca Laboratories Ltd. Mumbai, India. β-CD, Me-β-CD and HP-β-CD were obtained from Sigma Aldrich. The other analytical grade chemicals such as

sodium hydroxide, potassium hydrogen phosphate, sodium dihydrogen phosphate and polymers were procured from SD fine Chemicals, Chandigarh. Artesunate with β-CD, Me-β-CD or HP-β-CD was mixed in 1:1 molar ratio by different methods as given below: Physical mixing (PM): Physical mixtures were prepared by simple mixing of drug with the selected CD in a mortar and to ensure uniform mixing. The vials filled with Selleck NVP-BGJ398 the mixtures were subjected to vortex mixing for 5 min. Kneading (KN): Drug and CD’s were blended together in a mortar with sufficient INCB024360 mw water to produce a paste and was kneaded for 90 min. The product was then dried under vacuum at 40 °C for 48 h and passed through a 150 μm mesh and stored in a glass vial in a vacuum desiccator. Freeze-drying method (LY): The required 1:1 stoichiometric quantity of drug was added to an aqueous solution of the selected CD and was agitated on a magnetic stirrer for 24 h. The resulting solutions were frozen at (−80 °C) in a deep freezer for overnight. This was then lyophilized under 17.2 mTorr for 48 h. The samples were transferred immediately into a vacuum desiccator and dried over silica gel under vacuum for at least 24 h. Ternary complexes were

prepared by physical mixing, Kneading, Lyophilized suspension method (Ly Susp) and Coevaporation method. Coevaporated (CoE) solid system method: Equimolar amounts of artesunate and β-CD systems with 0.25% PEG were dissolved in water. The resulting solution was evaporated on a rotary evaporator at 60 °C to get a solid residue. The prepared system was dried in vacuum desiccators. Characterization: Binary

and ternary inclusion complexes of artesunate were characterized in the solid phase by DSC, PXRD, FT-IR, mass spectrometry and in solution phase by solution calorimetry and NMR. Phase-solubility diagrams of artesunate for both binary and ternary systems with various CDs in phosphate buffer (pH 6.8) were obtained according to Higuchi Suplatast tosilate and Connors [25]. An excess amount of the sample was added to 10 mL buffer or CD buffered solutions with a concentration of w/v (2–20 mM) in 20 mL glass vials with or without a polymer (0.25% PEG). The suspensions were sealed and shaken in water-bath shaker (MSW-275, Macroscientific Works Pvt. Ltd., Delhi) at 37±0.5 °C for 24 h to ensure equilibrium. After equilibration, aliquots of the supernatant were withdrawn, filtered through 0.45 μm Millipore filter paper, and the artesunate content was determined spectrophotometerically at λ=240 nm (UV/vis Spectrophotometer (Perkin Elmer Lamda 15, USA). The presence of CDs did not interfere with the spectrophotometric assay of the drug. The standard plot of artesunate was prepared by dissolving a weighed amount of the drug in phosphate buffer pH 6.